Home LiteratureArticle Details
PMID: 1655560 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

An improved aminoglycoside resistance gene cassette for use in gram-negative bacteria and Streptomyces.

FEMS microbiology letters ·Vol. 65 ·No. 3 ·1991-07-01 ·Pages 261-4

Denis F, Brzezinski R

Abstract

A cloning cassette, carrying a modified amino-glycoside resistance gene (neo) from transposon Tn5 was constructed. Three restriction sites internal to the neo gene were eliminated by in vitro mutagenesis, allowing their use in designing new cloning vectors. The original, suboptimal transcription promoter was replaced with a synthetic sequence corresponding to the consensus for E. coli and Streptomyces promoters. The cassette has numerous restriction sites for easy subcloning of the promoter, the coding sequence or the whole gene.

Related Genes
neo
MeSH Terms
Amino Acid Sequence Aminoglycosides Anti-Bacterial Agents/pharmacology Base Sequence Cloning, Molecular DNA Transposable Elements/genetics Drug Resistance, Microbial/genetics Escherichia coli/drug effects,genetics Genes, Bacterial Genes, Synthetic/genetics Genetic Vectors/genetics Molecular Sequence Data Promoter Regions, Genetic/genetics Restriction Mapping Streptomyces/drug effects,genetics
Chemicals
Aminoglycosides Anti-Bacterial Agents DNA Transposable Elements
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Denis F
Département de Biologie, Faculté des Sciences, Université de Sherbrooke, Québec, Canada.
Brzezinski R
Article Info
Journal
FEMS microbiology letters
Abbr.
FEMS Microbiol Lett
ISSN
0378-1097
Published
1991-07-01
Pages
261-4
Language
English
Region
England
NLM ID
7705721
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com